Cargando…

Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria

BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-question headache screen with the International Headache Society (IHS) criteria in the diagnosis of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahab, Kolawole, Ugheoke, Asuwemhe, Okokhere, Peter, Ibekwe, Titus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Publications Office of Jimma University 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762953/
https://www.ncbi.nlm.nih.gov/pubmed/26949310
_version_ 1782417171823984640
author Wahab, Kolawole
Ugheoke, Asuwemhe
Okokhere, Peter
Ibekwe, Titus
author_facet Wahab, Kolawole
Ugheoke, Asuwemhe
Okokhere, Peter
Ibekwe, Titus
author_sort Wahab, Kolawole
collection PubMed
description BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-question headache screen with the International Headache Society (IHS) criteria in the diagnosis of migraine among Nigerians. METHODS: Using a multi-stage sampling technique, 1513 respondents were screened for migraine using both the IHS criteria and the 3-question headache screen. A statistical comparison of the two diagnostic methods was then done by determination of kappa coefficient, sensitivity and specificity. RESULTS: The prevalence of migraine obtained using the IHS criteria was 9.6% (95% CI, 8.1%–11.1%) while it was 8.3% (95% CI, 8.1%–8.5%) with the use of the 3-question headache screen. There was a good agreement between the IHS criteria and the 3-question headache screen (k=0.68, p<0.001). The 3-question headache screen had a sensitivity of 66.2% (95% CI, 58.5%–73.9%), specificity of 97.8% (95% CI, 97.0%–98.6%), positive predictive value of 76.2% (95% CI, 68.8%–83.6%) and a negative predictive value of 96.5% (95% CI, 95.5%–97.5%). CONCLUSION: The 3-question headache screen is sensitive and specific in making a rapid diagnosis of migraine among Nigerians. Its use is thus encouraged so that appropriate management of the condition can be initiated early in order to reduce associated disability.
format Online
Article
Text
id pubmed-4762953
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Research and Publications Office of Jimma University
record_format MEDLINE/PubMed
spelling pubmed-47629532016-03-04 Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria Wahab, Kolawole Ugheoke, Asuwemhe Okokhere, Peter Ibekwe, Titus Ethiop J Health Sci Original Article BACKGROUND: Migraine is a chronic episodic disorder that is still under-diagnosed and undertreated. A rapid diagnostic method is desirable so that treatment can be initiated early. We compared the 3-question headache screen with the International Headache Society (IHS) criteria in the diagnosis of migraine among Nigerians. METHODS: Using a multi-stage sampling technique, 1513 respondents were screened for migraine using both the IHS criteria and the 3-question headache screen. A statistical comparison of the two diagnostic methods was then done by determination of kappa coefficient, sensitivity and specificity. RESULTS: The prevalence of migraine obtained using the IHS criteria was 9.6% (95% CI, 8.1%–11.1%) while it was 8.3% (95% CI, 8.1%–8.5%) with the use of the 3-question headache screen. There was a good agreement between the IHS criteria and the 3-question headache screen (k=0.68, p<0.001). The 3-question headache screen had a sensitivity of 66.2% (95% CI, 58.5%–73.9%), specificity of 97.8% (95% CI, 97.0%–98.6%), positive predictive value of 76.2% (95% CI, 68.8%–83.6%) and a negative predictive value of 96.5% (95% CI, 95.5%–97.5%). CONCLUSION: The 3-question headache screen is sensitive and specific in making a rapid diagnosis of migraine among Nigerians. Its use is thus encouraged so that appropriate management of the condition can be initiated early in order to reduce associated disability. Research and Publications Office of Jimma University 2016-01 /pmc/articles/PMC4762953/ /pubmed/26949310 Text en Copyright © Jimma University, Research & Publications Office 2016
spellingShingle Original Article
Wahab, Kolawole
Ugheoke, Asuwemhe
Okokhere, Peter
Ibekwe, Titus
Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
title Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
title_full Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
title_fullStr Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
title_full_unstemmed Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
title_short Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria
title_sort validation of the 3-question headache screen in the diagnosis of migraine in nigeria
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762953/
https://www.ncbi.nlm.nih.gov/pubmed/26949310
work_keys_str_mv AT wahabkolawole validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria
AT ugheokeasuwemhe validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria
AT okokherepeter validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria
AT ibekwetitus validationofthe3questionheadachescreeninthediagnosisofmigraineinnigeria